F Westermann
Overview
Explore the profile of F Westermann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
1060
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fiaschetti G, Castelletti D, Zoller S, Schramm A, Schroeder C, Nagaishi M, et al.
Oncogene
. 2022 Dec;
42(2):168.
PMID: 36476835
No abstract available.
2.
Althoff K, Beckers A, Bell E, Nortmeyer M, Thor T, Sprussel A, et al.
Oncogene
. 2014 Sep;
34(26):3357-68.
PMID: 25174395
Neuroblastoma, a childhood cancer that originates from neural crest-derived cells, is the most common deadly solid tumor of infancy. Amplification of the MYCN oncogene, which occurs in approximately 20-25% of...
3.
Kocak H, Ackermann S, Hero B, Kahlert Y, Oberthuer A, Juraeva D, et al.
Cell Death Dis
. 2013 Apr;
4:e586.
PMID: 23579273
Neuroblastoma is an embryonal malignancy of the sympathetic nervous system. Spontaneous regression and differentiation of neuroblastoma is observed in a subset of patients, and has been suggested to represent delayed...
4.
Salm F, Cwiek P, Ghosal A, Lucia Buccarello A, Largey F, Wotzkow C, et al.
Oncogene
. 2012 Oct;
32(34):3944-53.
PMID: 23027129
Chemotherapeutic drug resistance is one of the major causes for treatment failure in high-risk neuroblastoma (NB), the most common extra cranial solid tumor in children. Poor prognosis is typically associated...
5.
Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma
Fiaschetti G, Castelletti D, Zoller S, Schramm A, Schroeder C, Nagaishi M, et al.
Oncogene
. 2011 Feb;
30(25):2823-35.
PMID: 21317922
Medulloblastoma (MB) is the most common malignant brain tumor in children. It is known that overexpression and/or amplification of the MYC oncogene is associated with poor clinical outcome, but the...
6.
Afanasyeva E, Mestdagh P, Kumps C, Vandesompele J, Ehemann V, Theissen J, et al.
Cell Death Differ
. 2011 Jan;
18(6):974-84.
PMID: 21233845
Several microRNA (miRNA) loci are found within genomic regions frequently deleted in primary neuroblastoma, including miR-885-5p at 3p25.3. In this study, we demonstrate that miR-885-5p is downregulated on loss of...
7.
Oberthuer A, Juraeva D, Li L, Kahlert Y, Westermann F, Eils R, et al.
Pharmacogenomics J
. 2010 Aug;
10(4):258-66.
PMID: 20676065
Microarray-based prediction of clinical endpoints may be performed using either a one-color approach reflecting mRNA abundance in absolute intensity values or a two-color approach yielding ratios of fluorescent intensities. In...
8.
Gogolin S, Dreidax D, Becker G, Ehemann V, Schwab M, Westermann F
Int J Clin Pharmacol Ther
. 2010 Jun;
48(7):489-91.
PMID: 20557856
No abstract available.
9.
Mestdagh P, Fredlund E, Pattyn F, Schulte J, Muth D, Vermeulen J, et al.
Oncogene
. 2009 Dec;
29(9):1394-404.
PMID: 19946337
Increased activity of MYC protein-family members is a common feature in many cancers. Using neuroblastoma as a tumor model, we established a microRNA (miRNA) signature for activated MYCN/c-MYC signaling in...
10.
Fischer M, Bauer T, Oberthur A, Hero B, Theissen J, Ehrich M, et al.
Oncogene
. 2009 Nov;
29(6):865-75.
PMID: 19901960
Imbalances in chromosome 11q occur in approximately 30% of primary neuroblastoma and are associated with poor outcome. It has been suggested that 11q loss constitutes a distinct clinico-genetic neuroblastoma subgroup...